As with many fibroproliferative conditions, DD is associated with alterations in Transforming Growth Factor (TGF)-β signaling pathways [19-25] and this cytokine promotes both collagen production and contractile myofibroblast development in this disease [26,27]. This evidence concerns the gene TGFB1 and dentin dysplasia.